An antenatal pertussis vaccination programme was introduced in 2012 in the UK in the
context of a national outbreak of pertussis. It has been shown that a lower antibody response …

Reduced-antigen, combined diphtheria, tetanus, and three-component acellular pertussis
vaccine (Tdap; Boostrix®) is indicated for booster vaccination against diphtheria, tetanus …

Three hundred and nineteen adolescents aged 10–12 years who had been previously
vaccinated with five doses of acellular pertussis-containing vaccines received single doses …

Background. Pertussis is increasingly recognized as an important cause of cough illness in
adolescents and adults. Purpose. To evaluate the safety and antibody response to a single …

Primary immunization at 3, 4.5, and 6 months and boosting between 15 and 27 months of
age with combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus …

[Immunogenicity and reactogenicity of a reduced antigen content diphtheria, tetanus and
acellular pertussis vaccine dTpa) in 10 to 11 years old children and in adults]. - Abstract - Europe …

Background: In the United States, diphtheria-tetanus-acellular pertussis (DTaP) and
inactivated poliovirus (IPV) booster vaccinations are recommended for children 4–6 years of …

Abstract▲ Boostrix® US formulation (hereafter referred to as Tdap) is a formulation of
reduced-antigen, combined diphtheria-tetanus-acellular pertussis vaccine, adsorbed onto …

Background Multivalent vaccines containing whole-cell pertussis (wP) antigens combined
with established diphtheria (D), tetanus (T), hepatitis B (HB), Haemophilus influenzae type b …

Introduction Routine infant primary series and toddler booster vaccination are associated
with waning of antibody levels over time, which can lead to an increased incidence of …